AMANDA DUARTE: Open Payments
NPI 1295146215 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 33 payments from 9 companies in 2025. Trend: 2023 $674 · 2024 $470 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $180 |
| Axsome Therapeutics, Inc. | 10 | $180 |
| Novo Nordisk Inc | 3 | $155 |
| ABBVIE INC. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $42 |
| Viatris Specialty LLC | 2 | $32 |
| Gilead Sciences, Inc. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, Wegovy, VRAYLAR, The Cologuard Plus Collection Kit, YUPELRI, NUEDEXTA, Ozempic.
Industry payments across MI — which companies pay providers there.
